TFF Pharmaceuticals, Inc.
TFF Pharmaceuticals, Inc. (TFFP) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · TFFP · as of Jun 9, 2026
Activity summary
Buy transactions
13
P-Purchase only
Sell transactions
2
12 Months
Buy/Sell ratio
6.50
Buy/Sell (by trades)
Overall sentiment
TFF Pharmaceuticals, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
TFFP insider buying and selling by quarter
TFFP insider selling · TFFP insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Recent insider transactions
TFFP executive sell shares · TFFP board member insider trading · TFFP insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 3, 2024 | Weisman Harlan F President and CEO · Director | Award | 27,480 | — | Form 4 |
| Jul 3, 2024 | Lee Catherine Chai-zon Director | Award | 1,583 | — | Form 4 |
| Jul 3, 2024 | MILLS ROBERT S Director | Award | 3,165 | — | Form 4 |
| Jul 3, 2024 | Roberts Brandi Director | Award | 3,165 | — | Form 4 |
| Jul 3, 2024 | COLEMAN KIRK ALLEN CFO | Award | 10,184 | — | Form 4 |
| Jul 3, 2024 | Mikhak Zamaneh Chief Medical Officer | Award | 10,184 | — | Form 4 |
| Jul 3, 2024 | ROCAMBOLI STEPHEN Director | Award | 3,165 | — | Form 4 |
| Jul 3, 2024 | KING THOMAS BRAXTON Director | Award | 1,583 | — | Form 4 |
| Aug 16, 2023 | CARLSON CAPITAL L P 10 percent owner | Sale | 1,000 | $392 | Form 4 |
| Aug 15, 2023 | Weisman Harlan F President and CEO · Director | Purchase | 600,000 | $150K | Form 4 |
| Aug 15, 2023 | ROCAMBOLI STEPHEN Director | Purchase | 20,000 | $5K | Form 4 |
| Aug 15, 2023 | Roberts Brandi Director | Purchase | 20,000 | $5K | Form 4 |
| Aug 15, 2023 | COLEMAN KIRK ALLEN CFO | Purchase | 20,000 | $5K | Form 4 |
| Aug 15, 2023 | MILLS ROBERT S Director | Purchase | 40,000 | $10K | Form 4 |
| Aug 15, 2023 | Mikhak Zamaneh Chief Medical Officer | Purchase | 120,000 | $30K | Form 4 |
| Mar 10, 2023 | ROCAMBOLI STEPHEN Director | Purchase | 13,000 | $10K | Form 4 |
| Mar 10, 2023 | COLEMAN KIRK ALLEN CFO | Purchase | 12,000 | $9K | Form 4 |
| Mar 10, 2023 | Weisman Harlan F President and CEO · Director | Purchase | 150,000 | $132K | Form 4 |
| Mar 10, 2023 | Mikhak Zamaneh Chief Medical Officer | Purchase | 15,000 | $12K | Form 4 |
| Dec 15, 2022 | Weisman Harlan F President and CEO | Purchase | 50,000 | $53K | Form 4 |
| Nov 22, 2022 | Fletcher Aaron G.L. Director | Purchase | 43,470 | $50K | Form 4 |
| Sep 29, 2022 | THURMAN RANDY H Director | Sale | 40,255 | $173K | Form 4 |
| May 18, 2022 | Weisman Harlan F Director | Purchase | 4,615 | $25K | Form 4 |
| May 18, 2022 | Weisman Harlan F Director | Purchase | 2,500 | $13K | Form 4 |
| May 16, 2022 | Fletcher Aaron G.L. Director | Purchase | 24,600 | $125K | Form 4 |
Weisman Harlan F
President and CEO · Director
Date
Jul 3
Shares
27,480
Price
—
Value
—
CARLSON CAPITAL L P
10 percent owner
Date
Aug 16
Shares
1,000
Price
$0.39
Value
$392
Weisman Harlan F
President and CEO · Director
Date
Aug 15
Shares
600,000
Price
$0.25
Value
$150K
Mikhak Zamaneh
Chief Medical Officer
Date
Aug 15
Shares
120,000
Price
$0.25
Value
$30K
Weisman Harlan F
President and CEO · Director
Date
Mar 10
Shares
150,000
Price
$0.88
Value
$132K
Mikhak Zamaneh
Chief Medical Officer
Date
Mar 10
Shares
15,000
Price
$0.82
Value
$12K
Weisman Harlan F
President and CEO
Date
Dec 15
Shares
50,000
Price
$1.06
Value
$53K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About TFFP insider trading
TFFP insider trades
TFF Pharmaceuticals, Inc. (TFFP) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including TFFP. Over the past 12 months, 0 insiders have filed transactions with the SEC. TFFP insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For TFF Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
TFFP insider trading · 5 questionsThe insiders of TFF Pharmaceuticals, Inc. (TFFP) include executives and directors such as TFFP, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026